According to one study, topical spironolactone is more effective than topical finasteride for both men women.
    Treatment 9/13/2021

    At a glance
    In this educational post, the primary subjects mentioned are
    💧 spironolactone (topical)
    💧 finasteride (topical)
    💊 finasteride (oral)
    💊 dutasteride (oral)
    💧 minoxidil (topical)
    💧 tretinoin (topical)
    the tone is 😐 neutral.

    Other terms

    Topical spironolactone is more effective than topical finasteride for treating hair loss in both men and women. Oral spironolactone can affect testosterone, but the topical form doesn't impact the endocrine system.
    View this post in the Community →

    Similar Community Posts Join

    5 / 1000+ results

    Related Research

    6 / 1000+ results
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      November 2020 in “Elsevier eBooks”
      Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.
      Androgenetic Alopecia: A Review and Emerging Treatments

      research Androgenetic Alopecia: A Review and Emerging Treatments

      1 citations, July 2017 in “Clinical research in dermatology”
      Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.